Overview

Pharmacodynamic Drug Interaction Between Cilostazol and Statins

Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate pharmacodynamic drug interaction between cilostazol and statins (simvastatin as a CYP3A substrate and rosuvastatin as a non-CYP3A substrate) in healthy male subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Samsung Medical Center
Treatments:
Cilostazol
Rosuvastatin Calcium
Simvastatin